Showing results (131-140 of 247) with videos related to
Sort By:
Pageof 25
Cancer Chemotherapy and Pharmacology|May 12, 2012
FOLFIRI as second-line chemotherapy for advanced pancreatic cancer: a GISCAD multicenter phase II studyAlberto Zaniboni, Enrico Aitini, Sandro Barni, et al.Cancers|August 17, 2019
Use of Antibiotics and Risk of Cancer: A Systematic Review and Meta-Analysis of Observational StudiesFausto Petrelli, Michele Ghidini, Antonio Ghidini, et al.Current Problems in Cancer|April 12, 2024
Platinum dose in neoadjuvant therapy for triple-negative breast cancer: A systematic review and network meta-analysisFausto Petrelli, Antonio Ghidini, Carmen Rea, et al.Therapeutic Advances in Medical Oncology|March 4, 2024
Adjuvant and neoadjuvant chemotherapy for MSI early gastric cancer: a systematic review and meta-analysisFausto Petrelli, Maria Antista, Francesca Marra, et al.Heliyon|September 12, 2024
First line therapy in stage IV BRAF mutated colorectal cancerFausto Petrelli, Maria Antista, Lorenzo Dottorini, et al.F1000Research|August 2, 2022
Better survival of patients with oligo- compared with polymetastatic cancers: a systematic review and meta-analysis of 173 studiesFausto Petrelli, Antonio Ghidini, Michele Ghidini, et al.Cancer Medicine|March 19, 2026
Prognostic Significance of MSI and EBV Positivity in PD-L1 Positive Gastric Cancer: A Systematic Review and Meta-AnalysisFausto Petrelli, Maria Antista, Antonio Ghidini, et al.Breast Care (Basel, Switzerland)|March 21, 2014
Peptide Receptor Radionuclide Therapy (PRRT) in a Patient Affected by Metastatic Breast Cancer with Neuroendocrine DifferentiationGiordano Savelli, Alberto Zaniboni, Francesco Bertagna, et al.BMC Cancer|September 2, 2020
Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018)Angela Damato, Francesco Iachetta, Lorenzo Antonuzzo, et al.International Journal of Colorectal Disease|March 29, 2020
A systematic review of salvage therapies in refractory metastatic colorectal cancerFausto Petrelli, Gianluca Perego, Antonio Ghidini, et al.Pageof 25